SA4503 8-Week Study in Major Depressive Disorder (MDD)

Mise à jour : Il y a 5 ans
Référence : NCT00551109

Femme et Homme

  • | Pays :
  • Finland
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to determine the efficacy of SA4503 compared to placebo in the treatment of subjects with major depressive disorder (MDD). Secondary, to evaluate the safety of SA4503 compared to placebo in subjects with MDD.


Critère d'inclusion

  • Depressive Disorder, Major

Liens